Treatment of mucosa associated lymphoid tissue lymphoma with a long‐term once‐weekly regimen of oral azithromycin: Results from the phase II MALT—A trial

The macrolide clarithromycin has been reported as active for therapy of mucosa associated lymphoid tissue (MALT) lymphoma. Pharmacokinetic properties, however, require continuous daily intake over a prolonged period of time. As the macrolide azithromycin is characterized by a long half‐life as well...

Descripción completa

Detalles Bibliográficos
Autores principales: Lagler, Heimo, Kiesewetter, Barbara, Dolak, Werner, Obermueller, Markus, Simonitsch‐Klupp, Ingrid, Lukas, Julius, Neuper, Ortrun, Lamm, Wolfgang W., Mayerhoefer, Marius E., Raderer, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585850/
https://www.ncbi.nlm.nih.gov/pubmed/30153341
http://dx.doi.org/10.1002/hon.2555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585850/
https://www.ncbi.nlm.nih.gov/pubmed/30153341
http://dx.doi.org/10.1002/hon.2555

Ejemplares similares